- Home
- IMNM vs TBLD Comparison
IMNM vs TBLD Comparison
Compare IMNM & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- TBLD
- Stock Information
- Founded
- IMNM 2006
- TBLD 2021
- Country
- IMNM United States
- TBLD United States
- Employees
- IMNM N/A
- TBLD N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- TBLD Investment Managers
- Sector
- IMNM Health Care
- TBLD Finance
- Exchange
- IMNM Nasdaq
- TBLD Nasdaq
- Market Cap
- IMNM 585.5M
- TBLD 530.3M
- IPO Year
- IMNM 2020
- TBLD N/A
- Fundamental
- Price
- IMNM $9.99
- TBLD $16.78
- Analyst Decision
- IMNM Strong Buy
- TBLD
- Analyst Count
- IMNM 5
- TBLD 0
- Target Price
- IMNM $28.60
- TBLD N/A
- AVG Volume (30 Days)
- IMNM 881.8K
- TBLD 99.9K
- Earning Date
- IMNM 11-13-2024
- TBLD 01-01-0001
- Dividend Yield
- IMNM N/A
- TBLD 7.85%
- EPS Growth
- IMNM N/A
- TBLD N/A
- EPS
- IMNM N/A
- TBLD N/A
- Revenue
- IMNM $10,129,000.00
- TBLD N/A
- Revenue This Year
- IMNM N/A
- TBLD N/A
- Revenue Next Year
- IMNM N/A
- TBLD N/A
- P/E Ratio
- IMNM N/A
- TBLD N/A
- Revenue Growth
- IMNM N/A
- TBLD N/A
- 52 Week Low
- IMNM $8.97
- TBLD $13.44
- 52 Week High
- IMNM $30.96
- TBLD $16.26
- Technical
- Relative Strength Index (RSI)
- IMNM 40.28
- TBLD 60.78
- Support Level
- IMNM $9.24
- TBLD $16.19
- Resistance Level
- IMNM $11.06
- TBLD $16.50
- Average True Range (ATR)
- IMNM 0.74
- TBLD 0.23
- MACD
- IMNM -0.06
- TBLD 0.06
- Stochastic Oscillator
- IMNM 31.78
- TBLD 95.16
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About TBLD Thornburg Income Builder Opportunities Trust
Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.